Emtricitabine

Emtriva 200 MG Capsulas

200 mg cápsula duraSpainMarketedAuthorised 1 Dec 2003

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Emtricitabine

Emtriva 200 MG Capsulas

200 mg cápsula duraSpainMarketedAuthorised 1 Dec 2003

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Romania · 200mg · caps. · Gilead Science International Limited

EMTRIVA 200mgRomania · 200mg · caps. · Gilead Sciences Ireland Uc

EmtrivaUnited States · 200MG · capsule · Gilead

EmtrivaUnited States · 10MG/ML · solution · Gilead

EmtricitabineUnited States · 200MG · capsule · Cipla

Packs

Pack	Code	Status
EMTRIVA 200 MG CAPSULAS, 30 cápsulas	781757

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Emtricitabine
Strength: 200 mg
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 1 Dec 2003
Registration: 03261001
Marketing authorisation holder: Gilead Sciences Ireland Unlimited Company
Procedure: EU centralised
Supply: Diagnóstico Hospitalario